BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bragazzi NL, Gianfredi V, Villarini M, Rosselli R, Nasr A, Hussein A, Martini M, Behzadifar M. Vaccines Meet Big Data: State-of-the-Art and Future Prospects. From the Classical 3Is ("Isolate-Inactivate-Inject") Vaccinology 1.0 to Vaccinology 3.0, Vaccinomics, and Beyond: A Historical Overview. Front Public Health 2018;6:62. [PMID: 29556492 DOI: 10.3389/fpubh.2018.00062] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 7.0] [Reference Citation Analysis]
Number Citing Articles
1 de la Fuente J, Contreras M. Vaccinomics: a future avenue for vaccine development against emerging pathogens. Expert Rev Vaccines 2021;:1-9. [PMID: 34582295 DOI: 10.1080/14760584.2021.1987222] [Reference Citation Analysis]
2 Andrei G. Vaccines and Antivirals: Grand Challenges and Great Opportunities. Front Virol 2021;1:666548. [DOI: 10.3389/fviro.2021.666548] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
3 Mellado B, Wu J, Kong JD, Bragazzi NL, Asgary A, Kawonga M, Choma N, Hayasi K, Lieberman B, Mathaha T, Mbada M, Ruan X, Stevenson F, Orbinski J. Leveraging Artificial Intelligence and Big Data to Optimize COVID-19 Clinical Public Health and Vaccination Roll-Out Strategies in Africa. Int J Environ Res Public Health 2021;18:7890. [PMID: 34360183 DOI: 10.3390/ijerph18157890] [Reference Citation Analysis]
4 Fiks AG, Nekrasova E, Hambidge SJ. Health Systems as a Catalyst for Immunization Delivery. Acad Pediatr 2021;21:S40-7. [PMID: 33958091 DOI: 10.1016/j.acap.2021.01.015] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Chatterjee D, Priyadarshini P, Das DK, Mushtaq K, Singh B, Agrewala JN. Deciphering the Structural Enigma of HLA Class-II Binding Peptides for Enhanced Immunoinformatics-based Prediction of Vaccine Epitopes. J Proteome Res 2020;19:4655-69. [PMID: 33103906 DOI: 10.1021/acs.jproteome.0c00405] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
6 Kumar P, Sunita, Dubey KK, Shukla P. Whole-Cell Vaccine Preparation: Options and Perspectives. Methods Mol Biol 2021;2183:249-66. [PMID: 32959248 DOI: 10.1007/978-1-0716-0795-4_13] [Reference Citation Analysis]
7 Bragazzi NL, Guglielmi O, Garbarino S. SleepOMICS: How Big Data Can Revolutionize Sleep Science. Int J Environ Res Public Health 2019;16:E291. [PMID: 30669659 DOI: 10.3390/ijerph16020291] [Cited by in Crossref: 19] [Cited by in F6Publishing: 11] [Article Influence: 6.3] [Reference Citation Analysis]
8 Cella P, Voglino G, Barberis I, Alagna E, Alessandroni C, Cuda A, D'Aloisio F, Dallagiacoma G, DE Nitto S, DI Gaspare F, Gallipoli O, Gentile L, Kundisov L, Navaro M, Provenzano S, Santangelo OE, Stefanizzi P, Gianfredi V. Resources for assessing parents' vaccine hesitancy: a systematic review of the literature. J Prev Med Hyg 2020;61:E340-73. [PMID: 33150224 DOI: 10.15167/2421-4248/jpmh2020.61.3.1448] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
9 Ciliberti R, Bragazzi NL, Bonsignore A. The Implementation of the Professional Role of the Community Pharmacist in the Immunization Practices in Italy to Counteract Vaccine Hesitancy. Pharmacy (Basel) 2020;8:E155. [PMID: 32854420 DOI: 10.3390/pharmacy8030155] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Russo G, Reche P, Pennisi M, Pappalardo F. The combination of artificial intelligence and systems biology for intelligent vaccine design. Expert Opin Drug Discov 2020;15:1267-81. [PMID: 32662677 DOI: 10.1080/17460441.2020.1791076] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
11 Ngabo D, Dong W, Ibeke E, Iwendi C, Masabo E. Tackling pandemics in smart cities using machine learning architecture. Math Biosci Eng 2021;18:8444-61. [PMID: 34814307 DOI: 10.3934/mbe.2021418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
12 Provenzano S, Santangelo OE, Armetta F, Gianfredi V, Firenze A. iViaggio: the app for safe traveling. Minerva Med 2019;110. [DOI: 10.23736/s0026-4806.19.06050-6] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Bartsch SM, Mitgang EA, Geller G, Cox SN, O'Shea KJ, Boyce A, Siegmund SS, Kahn J, Lee BY. What If the Influenza Vaccine Did Not Offer Such Variable Protection? J Infect Dis 2020;222:1138-44. [PMID: 32386323 DOI: 10.1093/infdis/jiaa240] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
14 Wong ZSY, Zhou J, Zhang Q. Artificial Intelligence for infectious disease Big Data Analytics. Infect Dis Health 2019;24:44-8. [PMID: 30541697 DOI: 10.1016/j.idh.2018.10.002] [Cited by in Crossref: 69] [Cited by in F6Publishing: 33] [Article Influence: 17.3] [Reference Citation Analysis]
15 Bragazzi NL, Dai H, Damiani G, Behzadifar M, Martini M, Wu J. How Big Data and Artificial Intelligence Can Help Better Manage the COVID-19 Pandemic. Int J Environ Res Public Health. 2020;17. [PMID: 32370204 DOI: 10.3390/ijerph17093176] [Cited by in Crossref: 76] [Cited by in F6Publishing: 42] [Article Influence: 38.0] [Reference Citation Analysis]
16 Gianfredi V, Moretti M, Fusco Moffa I. Burden of measles using disability-adjusted life years, Umbria 2013-2018. Acta Biomed 2020;91:48-54. [PMID: 32275267 DOI: 10.23750/abm.v91i3-S.9412] [Reference Citation Analysis]
17 Soldatou V, Soldatos A, Soldatos T. Examining Socioeconomic and Computational Aspects of Vaccine Pharmacovigilance. Biomed Res Int 2019;2019:6576483. [PMID: 30911546 DOI: 10.1155/2019/6576483] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
18 Gianfredi V, Santangelo OE, Provenzano S. Correlation between flu and Wikipedia's pages visualization. Acta Biomed 2021;92:e2021056. [PMID: 33682825 DOI: 10.23750/abm.v92i1.9790] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Santangelo OE, Provenzano S, Gianfredi V. Infodemiology of flu: Google trends-based analysis of Italians' digital behavior and a focus on SARS-CoV-2, Italy. J Prev Med Hyg 2021;62:E586-91. [PMID: 34909483 DOI: 10.15167/2421-4248/jpmh2021.62.3.1704] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
20 Robleda-Castillo R, Ros-Lucas A, Martinez-Peinado N, Alonso-Padilla J. An Overview of Current Uses and Future Opportunities for Computer-Assisted Design of Vaccines for Neglected Tropical Diseases. Adv Appl Bioinform Chem 2021;14:25-47. [PMID: 33623396 DOI: 10.2147/AABC.S258759] [Reference Citation Analysis]
21 Wadhwa A, Aljabbari A, Lokras A, Foged C, Thakur A. Opportunities and Challenges in the Delivery of mRNA-based Vaccines. Pharmaceutics 2020;12:E102. [PMID: 32013049 DOI: 10.3390/pharmaceutics12020102] [Cited by in Crossref: 54] [Cited by in F6Publishing: 59] [Article Influence: 27.0] [Reference Citation Analysis]
22 Ud-Din M, Albutti A, Ullah A, Ismail S, Ahmad S, Naz A, Khurram M, Haq MU, Afsheen Z, Bakri YE, Salman M, Shaker B, Tahir Ul Qamar M. Vaccinomics to Design a Multi-Epitopes Vaccine for Acinetobacter baumannii. Int J Environ Res Public Health 2022;19:5568. [PMID: 35564967 DOI: 10.3390/ijerph19095568] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
23 Acuña-Zegarra MA, Díaz-Infante S, Baca-Carrasco D, Olmos-Liceaga D. COVID-19 optimal vaccination policies: A modeling study on efficacy, natural and vaccine-induced immunity responses. Math Biosci 2021;337:108614. [PMID: 33961878 DOI: 10.1016/j.mbs.2021.108614] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
24 Bussio JI, Molina-Perea C, González-Aramundiz JV. Hyaluronic Acid Nanocapsules as a Platform for Needle-Free Vaccination. Pharmaceutics 2019;11:E246. [PMID: 31130688 DOI: 10.3390/pharmaceutics11050246] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]
25 Gentile L, Cuda A, Dallagiacoma G, Provenzano S, Santangelo OE, Navaro M, D’aloisio F, Gianfredi V. Opinion, knowledge and attitude of public health residents towards the new mandatory vaccination law in Italy. J Public Health (Berl ) 2021;29:659-69. [DOI: 10.1007/s10389-019-01171-4] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
26 Provenzano S, Gianfredi V, Santangelo OE. Insight the data: Wikipedia's researches and real cases of arboviruses in Italy. Public Health 2021;192:21-9. [PMID: 33607517 DOI: 10.1016/j.puhe.2020.12.010] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
27 Alter G, Ottenhoff TH, Joosten SA. Antibody glycosylation in inflammation, disease and vaccination. Seminars in Immunology 2018;39:102-10. [DOI: 10.1016/j.smim.2018.05.003] [Cited by in Crossref: 53] [Cited by in F6Publishing: 50] [Article Influence: 13.3] [Reference Citation Analysis]
28 Wallis J, Shenton DP, Carlisle RC. Novel approaches for the design, delivery and administration of vaccine technologies. Clin Exp Immunol 2019;196:189-204. [PMID: 30963549 DOI: 10.1111/cei.13287] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 5.3] [Reference Citation Analysis]
29 Ros-Lucas A, Correa-Fiz F, Bosch-Camós L, Rodriguez F, Alonso-Padilla J. Computational Analysis of African Swine Fever Virus Protein Space for the Design of an Epitope-Based Vaccine Ensemble. Pathogens 2020;9:1078. [PMID: 33371523 DOI: 10.3390/pathogens9121078] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Kennedy RB, Ovsyannikova IG, Palese P, Poland GA. Current Challenges in Vaccinology. Front Immunol. 2020;11:1181. [PMID: 32670279 DOI: 10.3389/fimmu.2020.01181] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 4.5] [Reference Citation Analysis]
31 Michel-Todó L, Bigey P, Reche PA, Pinazo MJ, Gascón J, Alonso-Padilla J. Design of an Epitope-Based Vaccine Ensemble for Animal Trypanosomiasis by Computational Methods. Vaccines (Basel) 2020;8:E130. [PMID: 32188062 DOI: 10.3390/vaccines8010130] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
32 Homma A, Freire MDS, Possas C. Vaccines for neglected and emerging diseases in Brazil by 2030: the "valley of death" and opportunities for RD&I in Vaccinology 4.0. Cad Saude Publica 2020;36Suppl 2:e00128819. [PMID: 33111747 DOI: 10.1590/0102-311X00128819] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]